_1777352142843_145525226.png&w=48&q=75){kind=small}
Rosatom starts new radioactive drug lines
Russian company Rosatom announced the operation of its first pilot production line at its new radiopharmaceuticals plant in the Kaluga region, aimed at meeting the local healthcare sector's needs for diagnosis and treatment of diseases, especially cancer. The plant is built according to Good Manufacturing Practices (GMP) standards and is expected to reach full production capacity by 2028. Currently, the factory produces radiopharmaceuticals based on isotopes such as Iodine-123, Iodine-131, and Technetium-99m, with a capacity to manufacture more than 100 bottles per shift. This development enhances Russia's independence in supplying these pharmaceuticals, reduces dependence on imports, and improves the quality of diagnostic and therapeutic services for patients.
Notice: This Is an AI-Generated Summary
Comments (0)